Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer

Molecular Biology of the Cell

Volumn 23, Issue 17, 2012, Pages 3357-3369

  Virtakoivu, Reetta ^a,b   Pellinen, Teijo ^a,c   Rantala, Juha K ^a,d   Perälä, Merja ^a   Ivaska, Johanna ^a,b  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN; BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA 200; PROTEIN KINASE B; PROTEIN KINASE B BETA; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FOCAL ADHESION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; UPREGULATION;

ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84865747484     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-03-0213     Document Type: Article

References (53)

1. Amato RJ, Jac J, Mohammad T, Saxena S (2008). Pilot study of rapamycin in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer 6, 97-102.
2. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ (2003). Overexpression of AKT2/protein kinase Bβ leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63, 196-206.
3. Arjonen A, Alanko J, Veltel S, Ivaska J (2012). Distinct recycling of active and inactive β1 integrins. Traffic 13, 610-625.
4. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. 1-integrin. Nat Cell Biol 11, 557-568.
6. Byron A, Humphries JD, Askari JA, Craig SE, Mould AP, Humphries MJ (2009). Anti-integrin monoclonal antibodies. J Cell Sci 122, 4009-4011.
7. Caswell P, Norman J (2008). Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 18, 257-263.
8. Caswell PT, et al. (2007). Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 13, 496-510.
9. Chandarlapaty S, Sawai A, Scaltriti M, Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen N (2011). AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer Cell 19, 58-71.
10. Chin YR, Toker A (2010). The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell 38, 333-344.
11. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K (2006). A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10, 459-472.
12. Dillon RL, Marcotte R, Hennessy BT, Woodgett JR, Mills GB, Muller WJ (2009). Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. Cancer Res 69, 5057-5064.
13. Dillon RL, Muller WJ (2010). Distinct biological roles for the akt family in mammary tumor progression. Cancer Res 70, 4260-4264.
14. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, Petrocca F, Martinvalet D, Song E, Lim B, Lieberman J (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4, e7181.
15. Elson-Schwab I, Lorentzen A, Marshall CJ (2010). MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 5, e13176.
16. Even-Ram S, Yamada KM (2005). Cell migration in 3D matrix. Curr Opin Cell Biol 17, 524-532.
17. Friedl P, Wolf K (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374.
18. Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T, Marchesan S, Gronholm M (2009). Regulation of integrin activity and signalling. Biochim Biophys Acta 1790, 431-444.
19. Gjerdrum C, et al. (2010). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA 107, 1124-1129.
20. Guertin DA, Sabatini DM (2009). The pharmacology of mTOR inhibition. Sci Signal 2, pe24.
21. Hognas G, Tuomi S, Veltel S, Mattila E, Murumagi A, Edgren H, Kallioniemi O, Ivaska J (2012). Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo. Oncogene 31, 3597-3606.
22. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ (2004). Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 64, 3171-3178.
23. Iliopoulos D, Polytarchou C, Hatziapostolou M, Kottakis F, Maroulakou IG, Struhl K, Tsichlis PN (2009). MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2, ra62.
24. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171, 1023-1034.
25. Ivaska J, Heino J (2011). Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol 27, 291-320.
26. Kilpinen S, et al. (2008). Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9, R139.
27. Kim C, Ye F, Ginsberg MH (2011). Regulation of integrin activation. Annu Rev Cell Dev Biol 27, 321-345.
28. Kuo JC, Han X, Hsiao CT, Yates JR, III, Waterman CM (2011). Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol 13, 383-393.
29. Le Page C, Koumakpayi IH, Alam-Fahmy M, Mes-Masson AM, Saad F (2006). Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer 94, 1906-1912.
30. Majumder PK, Sellers WR (2005). Akt-regulated pathways in prostate cancer. Oncogene 24, 7465-7474.
31. Manning BD, Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
32. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN (2007). Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 67, 167-177.
33. Mattila E, Auvinen K, Salmi M, Ivaska J (2008). The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling. J Cell Sci 121, 3570-3580.
34. Meijering E, Dzyubachyk O, Smal I (2012). Methods for cell and particle tracking. Methods Enzymol 504, 183-200.
35. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH (2006). Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18, 2262-2271.
36. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E (2010). Ligand-independent activation of c-Met by fibronectin and α(5)β(1)- integrin regulates ovarian cancer invasion and metastasis. Oncogene 30, 1566-1576.
37. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P (1998). Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17, 6622-6632.
38. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R (2008). Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 14, 325-330.
39. Pellinen T, Rantala JK, Arjonen A, Mpindi JP, Kallioniemi O, Ivaska J (2012). A functional genetic screen reveals new regulators of 1-integrin activity. J Cell Sci 125, 649-661.
40. Rantala JK, et al. (2011). SHARPIN is an endogenous inhibitor of β1-integrin integrin activation. Nat Cell Biol 11, 1315-1324.
41. Regent M, Planus E, Bouin AP, Bouvard D, Brunner M, Faurobert E, Millon-Fremillon A, Block MR, Albiges-Rizo C (2011). Specificities of β1 integrin signaling in the control of cell adhesion and adhesive strength. Eur J Cell Biol 90, 261-269.
42. Ruan GX, Kazlauskas A (2012). Axl is essential for VEGF-A-dependent activation of PI3K/Akt. EMBO J 31, 1692-1703.
43. Sakamoto S, McCann RO, Dhir R, Kyprianou N (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 70, 1885-1895.
44. Sawyers CL (2003). Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4, 343-348.
45. Shattil SJ, Kim C, Ginsberg MH (2010). The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 11, 288-300.
46. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS (2008). Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10, 1027-1038.
47. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J (2010). Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30, 1436-1448.
48. White DP, Caswell PT, Norman JC (2007). αvβ3 and α5β1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration. J Cell Biol 177, 515-525.
49. Winograd-Katz SE, Itzkovitz S, Kam Z, Geiger B (2009). Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown. J Cell Biol 186, 423-436.
50. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA (2003). Protein kinase Bα/Akt1 regulates placental development and fetal growth. J Biol Chem 278, 32124-32131.
51. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20, 539-550.
52. Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B (2007). Functional atlas of the integrin adhesome. Nat Cell Biol 9, 858-867.
53. Zhou GL, Tucker DF, Bae SS, Bhatheja K, Birnbaum MJ, Field J (2006). Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J Biol Chem 281, 36443-36453.